Product Information

FLUOXETINE HCL 20 MG CAPSULE is a generic product labeled by ScieGen Pharmaceuticals, Inc., priced at $0.0324 per EA under NDC 50228011430. Its NADAC has been published 282 times since Jun 26, 2019.

FDA first approved this application on Mar 16, 2015. Its Orange Book therapeutic-equivalence code is AB1 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

FLUOXETINE HCL 20 MG CAPSULE

Fluoxetine Hydrochloride
$0.0324per EA

Strength

20 mg/1

NDC

50228011430

Classification

Generic

Dosage Form

CAPSULE

Route

ORAL

Effective Date

10/23/2024

Active Ingredients

FLUOXETINE HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA204597

FDA Approved

3/16/2015

TE Code

AB1

On Market Since

3/16/2015

Pharmacological Classes

Serotonin Reuptake Inhibitor
Serotonin Uptake Inhibitors

Price Statistics

The NADAC for FLUOXETINE HCL 20 MG CAPSULE has been published 282 times since Jun 26, 2019, and over the history we have for it it has declined 2.5%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0324 per EA
All-time high$0.0348 (Nov 16, 2022)
All-time low$0.0275 (May 22, 2024)
Median price$0.0320
Average price$0.0318
Largest weekly change+12.8% (Aug 21, 2024)
Weeks tracked282
Tracking sinceJun 26, 2019

Price History

1W

N/A

1M

N/A

3M

N/A

6M

N/A

1Y

N/A

3Y

+4.2%

5Y

-4.9%

All

-2.5%

Last surveyed Nov 13, 2024 — this NDC no longer appears in the current weekly NADAC file.

Generic Alternatives

The matcher finds 9 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 11% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of FLUOXETINE HCL 20 MG CAPSULE?

The current National Average Drug Acquisition Cost (NADAC) for FLUOXETINE HCL 20 MG CAPSULE, manufactured by ScieGen Pharmaceuticals, Inc., is $0.0324 per EA (NDC 50228011430), effective Nov 13, 2024.

How has the price of FLUOXETINE HCL 20 MG CAPSULE changed over time?

Over the history we have for it, the NADAC for FLUOXETINE HCL 20 MG CAPSULE has declined 2.5%. It has been tracked across 282 weekly CMS publications since Jun 26, 2019.

What are the highest and lowest recorded NADAC prices for FLUOXETINE HCL 20 MG CAPSULE?

Since Jun 26, 2019, the NADAC for FLUOXETINE HCL 20 MG CAPSULE has ranged from a low of $0.0275 (May 22, 2024) to a high of $0.0348 (Nov 16, 2022), with a median of $0.0320 per EA.

Are there cheaper alternatives to FLUOXETINE HCL 20 MG CAPSULE?

Yes. 9 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, FLUOXETINE HCL 20 MG CAPSULE, is $0.0289 per EA — about 11% below FLUOXETINE HCL 20 MG CAPSULE.

Who manufactures FLUOXETINE HCL 20 MG CAPSULE?

FLUOXETINE HCL 20 MG CAPSULE (NDC 50228011430) is labeled by ScieGen Pharmaceuticals, Inc., and CMS classifies it as a generic product.